Fundraising data
Every disclosed round over €1m, tracked by the Sesamers data desk. Toggle the period, read the charts, download the reports.
Capital deployed by quarter
Capital deployed by quarter. Bar chart, 4 bars. Highest: Q3 26, €12.6B. Lowest: Q1 26, €4.1B. Highlighted: Q4 26. Values: Q1 26 €4.1B, Q2 26 €4.9B, Q3 26 €12.6B, Q4 26 €11.5B.
Source: Sesamers deals tracker · n = 789 rounds
Capital by sector
share of period totalRanking, 6 rows. 1. Unclassified 30.3%, 2. AI 20.2%, 3. Defence AI 9.2%, 4. Defence Tech 6.5%, 5. Gov Tech 3.5%, 6. Other 30.3%.
Rounds by stage
count shareBar chart, 6 rows. Pre-seed 15.1%, Seed 29.3%, Series A 19.4%, Series B 5.3%, Series C 2.7%, Other 28.3%.
Capital by country
share of period totalRanking, 6 rows. 1. United Kingdom 37.5%, 2. Germany 23.9%, 3. France 18.1%, 4. Spain 3.7%, 5. Netherlands 3.1%, 6. Rest of Europe 13.7%.
Round size distribution
share of round countBar chart, 4 rows. €1–3M 26.6%, €3–10M 32.6%, €10–25M 18%, €25M+ 22.8%.
Who writes the cheques
share of capital · verified investorsWho writes the cheques, share of capital. Donut chart, 5 slices. €11.5B Capital. Undisclosed 36% (36%), Venture capital 34% (34%), Other 16% (16%), Public 7% (7%), Private equity 7% (7%).
- Undisclosed36%
- Venture capital34%
- Other16%
- Public7%
- Private equity7%
Median round, trended
€ millions · selected period highlightedMedian round, trended, € millions. Line chart, 1 line. Median: Q1 26 €7.2M, Q2 26 €7.7M, Q3 26 €6M, Q4 26 €6M.
Periods with fewer than 5 rounds have no median and break the line.
Largest rounds - Q4 2026
All coverage →| Rank | Company | Stage | Sector | Lead | Amount |
|---|---|---|---|---|---|
| 01 | Isomorphic Labs | Series C | Unclassified | Greenoaks, Sequoia Capital | €4.6B |
| 02 | Fractile | Series C | Defence AI | lead not disclosed | €691.9M |
| 03 | Uforce | Series A | Autonomous Systems | Valor Equity Partners, UK National Wealth Fund | €633.4M |
| 04 | Legora | Series D+ | Unclassified | Atreides Management | €490.7M |
| 05 | Agile Robots | Series D+ | Unclassified | SoftBank | €452.4M |
| 06 | CMR Surgical | Equity | Unclassified | Stryker | €358.1M |
| 07 | OMass Therapeutics | Series C | Unclassified | Bain Capital Life Sciences, Forbion, Novo Holdings | €276.1M |
| 08 | Onodrim Industries | Series A | Defence Manufacturing | Lux Capital | €268.7M |
| No disclosed rounds in this period. | |||||
Totals are converted to EUR at editor-set rates (GBP 1.17 · USD 0.92 · CHF 1.06). Individual rounds are shown as announced.